Announcements Trials
Browse Landscape

Status

Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 9Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Rectal Neoplasms 2Radiation Injuries 2Prostatic Neoplasms 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms by Histologic Type 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Chronic Conditions 2Melanoma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Lung Neoplasms 2Leukemia, Myeloid 2Leukemia, Lymphoid 2Leukemia, Biphenotypic, Acute 2

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Patient Reported Outcome Measures × Clear all
NCT06586801 2024-09-19

The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China

Shanghai East Hospital

Not yet recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03053297 2018-02-08

PANORAMA

AstraZeneca

Terminated
89 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT02405247 2015-07-31

TAURAS

AstraZeneca

Terminated
400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡